Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis - PubMed (original) (raw)
. 1991 Oct 25;266(30):20124-30.
Affiliations
- PMID: 1939073
Free article
Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis
C P Quinn et al. J Biol Chem. 1991.
Free article
Abstract
Linker insertion mutagenesis was employed to create structural disruptions of the lethal factor (LF) protein of anthrax toxin to map functional domains. A dodecameric linker was inserted at 17 blunt end restriction enzyme sites throughout the gene. Paired MluI restriction sites within the linker allowed the inserts to be reduced from four to two amino acids. Shuttle vectors containing the mutated genes were transformed into the avirulent Bacillus anthracis UM23C1-1 for expression and secretion of the gene products. Mutations at five sites in the central one-third of the sequence made the protein unstable, and purified protein could not be obtained. Mutated LF proteins with insertions at the other sites were purified and assessed for toxic activity in a macrophage lysis assay and for their ability to bind to the protective antigen (PA) component of anthrax toxin, the receptor binding moiety. Most insertions located in the NH2-terminal one-third of the LF protein eliminated both toxicity and binding to PA, while all four insertions in the COOH-terminal one-third of the protein eliminated toxicity without affecting binding to PA. These data support the hypothesis that the NH2-terminal domain contains the structures required for binding to PA and the COOH-terminal domain contains the putative catalytic domain of LF.
Similar articles
- Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.
Arora N, Leppla SH. Arora N, et al. J Biol Chem. 1993 Feb 15;268(5):3334-41. J Biol Chem. 1993. PMID: 8429009 - The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity.
Singh Y, Klimpel KR, Quinn CP, Chaudhary VK, Leppla SH. Singh Y, et al. J Biol Chem. 1991 Aug 15;266(23):15493-7. J Biol Chem. 1991. PMID: 1651334 - A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
Singh Y, Chaudhary VK, Leppla SH. Singh Y, et al. J Biol Chem. 1989 Nov 15;264(32):19103-7. J Biol Chem. 1989. PMID: 2509473 - Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
Varughese M, Teixeira AV, Liu S, Leppla SH. Varughese M, et al. Infect Immun. 1999 Apr;67(4):1860-5. doi: 10.1128/IAI.67.4.1860-1865.1999. Infect Immun. 1999. PMID: 10085028 Free PMC article. - Anthrax toxin.
Bhatnagar R, Batra S. Bhatnagar R, et al. Crit Rev Microbiol. 2001;27(3):167-200. doi: 10.1080/20014091096738. Crit Rev Microbiol. 2001. PMID: 11596878 Review.
Cited by
- An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
Lim NK, Kim JH, Oh MS, Lee S, Kim SY, Kim KS, Kang HJ, Hong HJ, Inn KS. Lim NK, et al. Infect Immun. 2005 Oct;73(10):6547-51. doi: 10.1128/IAI.73.10.6547-6551.2005. Infect Immun. 2005. PMID: 16177329 Free PMC article. - Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.
Ascough S, Ingram RJ, Chu KK, Reynolds CJ, Musson JA, Doganay M, Metan G, Ozkul Y, Baillie L, Sriskandan S, Moore SJ, Gallagher TB, Dyson H, Williamson ED, Robinson JH, Maillere B, Boyton RJ, Altmann DM. Ascough S, et al. PLoS Pathog. 2014 May 1;10(5):e1004085. doi: 10.1371/journal.ppat.1004085. eCollection 2014 May. PLoS Pathog. 2014. PMID: 24788397 Free PMC article. - Membrane translocation by anthrax toxin.
Collier RJ. Collier RJ. Mol Aspects Med. 2009 Dec;30(6):413-22. doi: 10.1016/j.mam.2009.06.003. Epub 2009 Jun 27. Mol Aspects Med. 2009. PMID: 19563824 Free PMC article. Review. - Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum alpha-toxin.
Hong Y, Ohishi K, Inoue N, Kang JY, Shime H, Horiguchi Y, van der Goot FG, Sugimoto N, Kinoshita T. Hong Y, et al. EMBO J. 2002 Oct 1;21(19):5047-56. doi: 10.1093/emboj/cdf508. EMBO J. 2002. PMID: 12356721 Free PMC article. - Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies.
Varughese M, Chi A, Teixeira AV, Nicholls PJ, Keith JM, Leppla SH. Varughese M, et al. Mol Med. 1998 Feb;4(2):87-95. Mol Med. 1998. PMID: 9508786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources